Ethics & Informed Consent: Retrospective Case-Control Study (South Korea)

1. Ethical Principles & Legislative Framework

In research involving human participants, securing ethical clearance is a critical first step. For a Retrospective Case-Control Study being conducted in South Korea, study designs must align with the primary regulatory legislation: Bioethics and Safety Act. This statutory framework ensures participant welfare, confidentiality, and voluntary involvement are protected.

Administrative review and formal approval are managed by a local or regional Institutional Review Board (IRB). Researchers must secure full approval or a formal exemption certificate from this board before recruiting any participants or commencing data collection.

2. Study Design Elements & Reporting Integrity

For a Retrospective Case-Control Study, the review board places significant focus on methodological transparency. The application must outline the research rationale, recruitment protocols, inclusion and exclusion criteria, and data protection measures.

Study Classification: Minimal Risk (Exempt or Expedited)

Case-control studies rely on historical data extraction. When active consent is unfeasible, a waiver can be requested by proving secure de-identification and minimal participant risk.

To guarantee academic integrity and reproducibility, the study report and subsequent publications should follow the internationally recognised reporting standard: STROBE guidelines.

3. Informed Consent & Information Sheet Guidelines

A robust participant information sheet and informed consent form are critical parts of the ethical application. Ensure your documentation incorporates the following components:

• Plain Language Explanations: Avoid complex medical or technical terminology. Ensure readability matches the general population.
• Voluntary Participation: Explicitly state that participation is entirely voluntary and that individuals can withdraw at any time without negative consequences.
• Confidentiality & Data Controls: Explain how participant data will be anonymised or pseudonymised, who will have access to it, and how long it will be securely retained under Personal Information Protection Act (PIPA).
• Risk/Benefit Disclosure: Clearly list any potential risks, discomforts, or direct benefits associated with participation in the study.
• Ethics Board Contact Information: Provide the contact details of the reviewing Institutional Review Board (IRB) so participants can reach out if they have questions or concerns.

Research Ethics, Clinical Trials & Institutional Governance

Upholding patient privacy during this Retrospective Case-Control Study in South Korea is guided by the Belmont Report principles for data stewardship. The protocol must outline safe pathways, particularly if any minor deception in psychological research is used in questionnaires. A standardized research study consent form guarantees that all participants are fully informed under informed consent Belmont Report rules. While observational work rarely requires a clinical trial registration, a signed clinical trial agreement contract is required for health networks. These tracking studies do not utilize live animals regulated by the 3rs replacement reduction refinement guidelines. In accordance with South Korea participant safety rules, investigators must complete certified human protection modules before recruitment begins.

4. Regulatory Checklist Table

To streamline your ethical review submission, use the structured alignment checklist below:

6. Frequently Asked Questions